English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model Journal article
Chang, Zhen, Gao, Dan, Liao, Liying, Sun, Junqing, Zhang, Gen, Zhang, Xue, Wang, Feiran, Li, Chunrui, Oladejo, Babayemi Olawale, Li, Shihua, Chai, Yan, Hu, Yongfei, Lu, Xuancheng, Xiao, Haixia, Qi, Jianxun, Chen, Zhihai, Gao, Feng, Wu, Yan. Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model[J]. Proceedings of the National Academy of Sciences of the United States of America, 2024, 121(24), e2400163121.
Authors:  Chang, Zhen;  Gao, Dan;  Liao, Liying;  Sun, Junqing;  Zhang, Gen; et al.
Favorite | TC[WOS]:5 TC[Scopus]:4  IF:9.4/10.8 | Submit date：2024/07/04
Bispecific Antibody  Bunyavirus  Glycoproteins  Sftsv  Structural Basis  
Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus Journal article
Wang, Han, Yin, Peng, Zheng, Tingting, Qin, Lanju, Li, Shihua, Han, Pu, Qu, Xiao, Wen, Jun, Ding, Haoyi, Wu, Jiahao, Kong, Tianxiang, Gao, Zhengrong, Hu, Songtao, Zhao, Xin, Cao, Xiangyu, Fang, Min, Qi, Jianxun, Xi, Jianzhong Jeff, Duan, Kai, Yang, Xiaoming, Zhang, Zhuobing, Wang, Qihui, Tan, Wenjie, Gao, George Fu. Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus[J]. Nature Immunology, 2024, 25(2), 307-315.
Authors:  Wang, Han;  Yin, Peng;  Zheng, Tingting;  Qin, Lanju;  Li, Shihua; et al.
Favorite | TC[WOS]:13 TC[Scopus]:10  IF:27.7/28.3 | Submit date：2024/02/22
Publisher Correction: Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus (Nature Immunology, (2024), 25, 2, (307-315), 10.1038/s41590-023-01715-7) Other
2024-01-15
Authors:  Wang, Han;  Yin, Peng;  Zheng, Tingting;  Qin, Lanju;  Li, Shihua; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1 | Submit date：2024/02/22
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 Journal article
Rao, Xia, Zhao, Runchu, Tong, Zhou, Guo, Shuxin, Peng, Weiyu, Liu, Kefang, Li, Shihua, Wu, Lili, Tong, Jianyu, Chai, Yan, Han, Pu, Wang, Feiran, Jia, Peng, Li, Zhaohui, Zhao, Xin, Li, Dedong, Zhang, Rong, Zhang, Xue, Zou, Weiwei, Li, Weiwei, Wang, Qihui, Gao, George Fu, Wu, Yan, Dai, Lianpan, Gao, Feng. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2[J]. Proceedings of the National Academy of Sciences of the United States of America, 2023, 120(52), e2314193120.
Authors:  Rao, Xia;  Zhao, Runchu;  Tong, Zhou;  Guo, Shuxin;  Peng, Weiyu; et al.
Favorite | TC[WOS]:13 TC[Scopus]:12  IF:9.4/10.8 | Submit date：2024/01/02
Cryptic Epitope  Neutralizing Antibody  Omicron Ba.4/ba.5/bq.1.1/xbb Subvariant  Rbd-8  Sars-cov-2  
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms Journal article
Rongjia Zhu, Tingdong Yan, Yingmei Feng, Yan Liu, Hongcui Cao, Gongxin Peng, Yanlei Yang, Zhen Xu, Jingqi Liu, Wei Hou, Xiaoyue Wang, Zhe Li, Luchan Deng, Shihua Wang, Jing Li, Qin Han, Hongling Li, Guangliang Shan, Yinghao Cao, Xingyan An, Jianshe Yan, Zhonghui Zhang, Huafei Li, Xuebin Qu, Jiaqi Zhu, Shumin Zhou, Jiao Wang, Fengchun Zhang, Jinming Gao, Ronghua Jin, Dayong Xu, Yan Qing Ma, Tao Huang, Shuang Peng, Zhi Zheng, Ilia Stambler, Eric Gilson, Lee Wei Lim, Alexey Moskalev, Antonio Cano, Sasanka Chakrabarti, Brun Ulfhake, Huanxing Su, Haoying Xu, Sihuan Xu, Feng Wei, Holly M. Brown-Borg, Kyung Jin Min, Georgina Ellison-Hughes, Calogero Caruso, Kunlin Jin, Robert Chunhua Zhao. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms[J]. Cell Research, 2021, 31(12), 1244-1262.
Authors:  Rongjia Zhu;  Tingdong Yan;  Yingmei Feng;  Yan Liu;  Hongcui Cao; et al.
Favorite | TC[WOS]:88 TC[Scopus]:92  IF:28.1/36.4 | Submit date：2022/01/14
Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia Journal article
Leng,Zikuan, Zhu,Rongjia, Hou,Wei, Feng,Yingmei, Yang,Yanlei, Han,Qin, Shan,Guangliang, Meng,Fanyan, Du,Dongshu, Wang,Shihua, Fan,Junfen, Wang,Wenjing, Deng,Luchan, Shi,Hongbo, Li,Hongjun, Hu,Zhongjie, Zhang,Fengchun, Gao,Jinming, Liu,Hongjian, Li,Xiaoxia, Zhao,Yangyang, Yin,Kan, He,Xijing, Gao,Zhengchao, Wang,Yibin, Yang,Bo, Jin,Ronghua, Stambler,Ilia, Lim,Lee Wei, Su,Huanxing, Moskalev,Alexey, Cano,Antonio, Chakrabarti,Sasanka, Min,Kyung Jin, Ellison-Hughes,Georgina, Caruso,Calogero, Jin,Kunlin, Zhao,Robert Chunhua. Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia[J]. Aging and Disease, 2020, 11(2), 216-228.
Authors:  Leng,Zikuan;  Zhu,Rongjia;  Hou,Wei;  Feng,Yingmei;  Yang,Yanlei; et al.
Favorite | TC[WOS]:840 TC[Scopus]:951  IF:7.0/7.1 | Submit date：2021/03/01
Ace2 Negative  Cell Transplantation  Covid-19  Function Recovery  Immunomodulation  Mesenchymal Stem Cells